Pancreatic Cancer Research

ResearcherNingbo UniversityActive in the last 2 years

Caide Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9588-2218; OpenAlex author ID A5016522415. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 11

  1. Plasma fatty acids, genetic risk, and incident pancreatic cancer: A prospective cohort study. Last author DOI 10.1016/j.pan.2025.11.013↗
  2. Comparison of laparoscopic versus open pancreaticoduodenectomy combined with portal vein/superior mesenteric vein resection and reconstruction for pancreatic c… Co-author DOI 10.21037/gs-23-538↗
  3. Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma. Co-author DOI 10.1038/s41598-022-16155-w↗
  4. Risk Factors of Early Liver Metastasis for Pancreatic Ductal Adenocarcinoma after Radical Resection. Last author DOI 10.1155/2022/8061879↗
  5. Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection. Last author DOI 10.3389/fonc.2022.1040411↗
  6. Laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancreatic cancer: a single-institution comparative study. Co-author DOI 10.21037/gs-21-56↗
  7. LITAF is a potential tumor suppressor in pancreatic cancer. Last author DOI 10.18632/oncotarget.23220↗
  8. Portal vein/superior mesenteric vein resection in pancreatic cancer treatment in the elderly. First author DOI 10.1097/md.0000000000007335↗
  9. Vitamin C Intake and Pancreatic Cancer Risk: A Meta-Analysis of Published Case-Control and Cohort Studies. Last author DOI 10.1371/journal.pone.0148816↗
  10. [Value and safety of the surgery with vascular resection and reconstruction for pancreatic cancer]. First author DOI 10.3760/cma.j.issn.0529-5815.2016.01.014↗
  11. Construction of orthotopic xenograft mouse models for human pancreatic cancer. First author DOI 10.3892/etm.2015.2642↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Changjiang Lu · 2 shared papers, 2022 · strength 0.39
  2. Jingshu Tong · 2 shared papers, 2022 · strength 0.39
  3. Jing Huang · 4 shared papers, 2016–2021 · strength 0.38
  4. Wei Jiang · 1 shared paper, 2026 · strength 0.32
  5. Jiongze Fang · 2 shared papers, 2017–2024 · strength 0.31
  6. Zhengwei Lin · 1 shared paper, 2024 · strength 0.22
  7. Lei Dai · 1 shared paper, 2022 · strength 0.20
  8. Wei Jiang · 1 shared paper, 2022 · strength 0.20
  9. Xiujun Cai · 1 shared paper, 2021 · strength 0.16
  10. Jie Zhou · 1 shared paper, 2017 · strength 0.09
  11. Yongfei Hua · 1 shared paper, 2016 · strength 0.07
  12. Wei Jiang · 1 shared paper, 2016 · strength 0.07
  13. Yuan Zhou · 1 shared paper, 2018 · strength 0.07
  14. Jeff Xiwu Zhou · 1 shared paper, 2015 · strength 0.06
  15. Lei Dai · 1 shared paper, 2015 · strength 0.06
  16. Bin Huang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.